Intact Investment Management Inc. Zoetis Inc. Transaction History

Intact Investment Management Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$160.94 - $186.23 $64,376 - $74,492	-400 Reduced 23.53%	1,300 $223,000
Q1 2023 May 12, 2023	SELL	$145.48 - $175.02 $480,083 - $577,566	-3,300 Reduced 66.0%	1,700 $282,000
Q4 2022 Feb 14, 2023	SELL	$131.14 - $157.47 $13,113 - $15,747	-100 Reduced 1.96%	5,000 $732,000
Q3 2022 Nov 14, 2022	BUY	$148.29 - $182.55 $252,093 - $310,335	1,700 Added 50.0%	5,100 $757,000
Q2 2022 Aug 11, 2022	BUY	$155.97 - $200.09 $530,298 - $680,306	3,400 New	3,400 $584,000

1,923

424M

1.15M

1.2M

Ticker ZTS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 468,139,008
Market Cap $83.7B
Description
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...

Get notified when there are updates to the investment portfolio of Intact Investment Management Inc., based on Form 13F filings with the SEC.

Stay updated on Intact Investment Management Inc. with notifications on news.